Page last updated: 2024-10-22

ambroxol and Influenza, Human

ambroxol has been researched along with Influenza, Human in 2 studies

Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research Excerpts

ExcerptRelevanceReference
"Human IAV and murine parainfluenza virus type 1 Sendai virus are exclusively pneumotropic, and the infectious organ tropism of these viruses is determined by the susceptibility of the viral envelope glycoprotein to cleavage by proteases in the airway."2.42Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential. ( Higashi, Y; Kido, H; Mizuno, D; Okumura, Y; Yamada, H; Yano, M, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kido, H2
Okumura, Y2
Yamada, H2
Mizuno, D1
Higashi, Y1
Yano, M2
Le, TQ1

Reviews

2 reviews available for ambroxol and Influenza, Human

ArticleYear
Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential.
    Biological chemistry, 2004, Volume: 385, Issue:11

    Topics: Ambroxol; Expectorants; Humans; Influenza A virus; Influenza, Human; Pneumonia; Proteinase Inhibitor

2004
Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
    Current pharmaceutical design, 2007, Volume: 13, Issue:4

    Topics: Ambroxol; Animals; Antiviral Agents; Brain; Clarithromycin; Drug Therapy, Combination; Expectorants;

2007